Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents.

Schubert-Bast S, Willems LM, Kurlemann G, Knake S, Müller-Schlüter K, Rosenow F, Strzelczyk A.

Epilepsy Behav. 2018 Oct 31;89:89-93. doi: 10.1016/j.yebeh.2018.10.018. [Epub ahead of print]

PMID:
30390435
2.

Prevalence, risk factors and therapeutic aspects of injuries and accidents in women with epilepsy.

Verboket RD, Söhling N, Marzi I, Paule E, Knake S, Rosenow F, Strzelczyk A, Willems LM.

Eur J Trauma Emerg Surg. 2018 Oct 11. doi: 10.1007/s00068-018-1030-8. [Epub ahead of print]

PMID:
30310959
3.

Focused review on seizures caused by meningiomas.

Baumgarten P, Sarlak M, Baumgarten G, Marquardt G, Seifert V, Strzelczyk A, Rosenow F, Freiman TM.

Epilepsy Behav. 2018 Nov;88:146-151. doi: 10.1016/j.yebeh.2018.09.002. Epub 2018 Sep 27. Review.

PMID:
30269033
4.

Hemispheric language lateralization in presurgical patients with temporal lobe epilepsy: Improving the retest reliability of functional transcranial Doppler sonography.

Conradi N, Hermsen A, Krause K, Gorny I, Strzelczyk A, Knake S, Rosenow F.

Epilepsy Behav. 2018 Sep 11. pii: S1525-5050(18)30254-3. doi: 10.1016/j.yebeh.2018.08.014. [Epub ahead of print] Review.

PMID:
30217756
5.

Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany.

Willems LM, Bertsche A, Bösebeck F, Hornemann F, Immisch I, Klein KM, Knake S, Kunz R, Kurlemann G, Langenbruch L, Möddel G, Müller-Schlüter K, von Podewils F, Reif PS, Steinhoff BJ, Steinig I, Rosenow F, Schubert-Bast S, Strzelczyk A.

Front Neurol. 2018 Jul 23;9:569. doi: 10.3389/fneur.2018.00569. eCollection 2018.

6.

Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data.

Rohracher A, Zimmermann G, Villanueva V, Garamendi I, Sander JW, Wehner T, Shankar R, Ben-Menachem E, Brodie MJ, Pensel MC, Di Gennaro G, Maurousset A, Strzelczyk A, Rheims S, Rácz A, Menzler K, Bertol-Alegre V, García-Morales I, López-González FJ, Toledo M, Carpenter KJ, Trinka E.

Epilepsia. 2018 Sep;59(9):1727-1739. doi: 10.1111/epi.14520. Epub 2018 Jul 25. Erratum in: Epilepsia. 2018 Nov;59(11):2167.

PMID:
30047129
7.

Use of Emergency Medication in Adult Patients with Epilepsy: A Multicentre Cohort Study from Germany.

Kadel J, Bauer S, Hermsen AM, Immisch I, Kay L, Klein KM, Knake S, Menzler K, Reif PS, Rosenow F, Strzelczyk A.

CNS Drugs. 2018 Aug;32(8):771-781. doi: 10.1007/s40263-018-0544-2.

PMID:
30019316
8.

Incidence, Risk Factors and Consequences of Epilepsy-Related Injuries and Accidents: A Retrospective, Single Center Study.

Willems LM, Watermann N, Richter S, Kay L, Hermsen AM, Knake S, Rosenow F, Strzelczyk A.

Front Neurol. 2018 Jun 15;9:414. doi: 10.3389/fneur.2018.00414. eCollection 2018.

9.

Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus.

Strzelczyk A, Kay L, Bauer S, Immisch I, Klein KM, Knake S, Kowski A, Kunz R, Kurlemann G, Langenbruch L, Möddel G, Müller-Schlüter K, Reif PS, Schubert-Bast S, Steinhoff BJ, Steinig I, Willems LM, von Podewils F, Rosenow F.

Epilepsia. 2018 Aug;59(8):1549-1556. doi: 10.1111/epi.14476. Epub 2018 Jun 25.

PMID:
29943451
10.

The role of mTOR inhibitors in preventing epileptogenesis in patients with TSC: Current evidence and future perspectives.

Schubert-Bast S, Rosenow F, Klein KM, Reif PS, Kieslich M, Strzelczyk A.

Epilepsy Behav. 2018 Jun 22. pii: S1525-5050(18)30272-5. doi: 10.1016/j.yebeh.2018.05.039. [Epub ahead of print] Review.

PMID:
29941212
11.

Invasive EEG-electrodes in presurgical evaluation of epilepsies: Systematic analysis of implantation-, video-EEG-monitoring- and explantation-related complications, and review of literature.

Willems LM, Reif PS, Spyrantis A, Cattani A, Freiman TM, Seifert V, Wagner M, You SJ, Schubert-Bast S, Bauer S, Klein KM, Rosenow F, Strzelczyk A.

Epilepsy Behav. 2018 Jun 13. pii: S1525-5050(18)30253-1. doi: 10.1016/j.yebeh.2018.05.012. [Epub ahead of print]

PMID:
29907526
12.

[Psychogenic non epileptic seizures : Differential diagnostic features].

Reif PS, Willems LM, Strzelczyk A, Klein KM, Rosenow F.

Herzschrittmacherther Elektrophysiol. 2018 May 14. doi: 10.1007/s00399-018-0557-z. [Epub ahead of print] Review. German.

PMID:
29761337
13.

Noncompliance of patients with driving restrictions due to uncontrolled epilepsy.

Willems LM, Reif PS, Knake S, Hamer HM, Willems C, Krämer G, Rosenow F, Strzelczyk A.

Epilepsy Behav. 2018 May 9. pii: S1525-5050(18)30252-X. doi: 10.1016/j.yebeh.2018.04.008. [Epub ahead of print]

PMID:
29752000
14.

Ondine's curse and temporal lobe seizures: anti-Hu- and Zic4-associated paraneoplastic brainstem and limbic encephalitis.

Kay L, Bauer S, Koczulla AR, Librizzi D, Vadasz D, Knake S, Rosenow F, Strzelczyk A.

Eur J Neurol. 2018 May;25(5):e59-e60. doi: 10.1111/ene.13629. No abstract available.

PMID:
29667352
15.

Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview.

Willems LM, Richter S, Watermann N, Bauer S, Klein KM, Reese JP, Schöffski O, Hamer HM, Knake S, Rosenow F, Strzelczyk A.

Epilepsy Behav. 2018 Jun;83:28-35. doi: 10.1016/j.yebeh.2018.03.025. Epub 2018 Apr 9.

PMID:
29649671
16.

Intravenous lacosamide for treatment of absence status epilepticus in genetic generalized epilepsy: A case report and review of literature.

Reif PS, Männer A, Willems LM, Kay L, Zöllner JP, Klein KM, Rosenow F, Strzelczyk A.

Acta Neurol Scand. 2018 Sep;138(3):259-262. doi: 10.1111/ane.12935. Epub 2018 Apr 6. Review.

PMID:
29633241
17.

Limitations of a Short Demographic Questionnaire for Bedside Estimation of Patients' Global Cognitive Functioning in Epilepsy Patients.

Gorny I, Krause K, Albert A, Schneider S, Möller L, Habermehl L, Strzelczyk A, Rosenow F, Hermsen A, Knake S, Menzler K.

Front Neurol. 2018 Mar 1;9:85. doi: 10.3389/fneur.2018.00085. eCollection 2018.

18.

Robot-guided stereoelectroencephalography without a computed tomography scan for referencing: Analysis of accuracy.

Spyrantis A, Cattani A, Strzelczyk A, Rosenow F, Seifert V, Freiman TM.

Int J Med Robot. 2018 Apr;14(2). doi: 10.1002/rcs.1888. Epub 2018 Jan 8.

PMID:
29316270
19.

The Burden of Severely Drug-Refractory Epilepsy: A Comparative Longitudinal Evaluation of Mortality, Morbidity, Resource Use, and Cost Using German Health Insurance Data.

Strzelczyk A, Griebel C, Lux W, Rosenow F, Reese JP.

Front Neurol. 2017 Dec 22;8:712. doi: 10.3389/fneur.2017.00712. eCollection 2017.

20.

Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence.

Willems LM, Zöllner JP, Paule E, Schubert-Bast S, Rosenow F, Strzelczyk A.

Expert Rev Clin Pharmacol. 2018 Mar;11(3):309-324. doi: 10.1080/17512433.2018.1421066. Epub 2017 Dec 29. Review.

PMID:
29285947
21.

Periodic EEG patterns in sporadic Creutzfeld-Jakob-Disease can be benzodiazepine-responsive and be difficult to distinguish from non-convulsive status epilepticus.

Marquetand J, Knake S, Strzelczyk A, Steinhoff BJ, Lerche H, Synofzik M, Focke NK.

Seizure. 2017 Dec;53:47-50. doi: 10.1016/j.seizure.2017.10.023. Epub 2017 Nov 4.

PMID:
29125945
22.

Significant increase in acute subdural hematoma in octo- and nonagenarians: surgical treatment, functional outcome, and predictors in this patient cohort.

Won SY, Dubinski D, Brawanski N, Strzelczyk A, Seifert V, Freiman TM, Konczalla J.

Neurosurg Focus. 2017 Nov;43(5):E10. doi: 10.3171/2017.7.FOCUS17417.

PMID:
29088952
23.

Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany.

Kortland LM, Knake S, von Podewils F, Rosenow F, Strzelczyk A.

Front Neurol. 2017 Sep 26;8:507. doi: 10.3389/fneur.2017.00507. eCollection 2017.

24.

Personalized translational epilepsy research - Novel approaches and future perspectives: Part I: Clinical and network analysis approaches.

Rosenow F, van Alphen N, Becker A, Chiocchetti A, Deichmann R, Deller T, Freiman T, Freitag CM, Gehrig J, Hermsen AM, Jedlicka P, Kell C, Klein KM, Knake S, Kullmann DM, Liebner S, Norwood BA, Omigie D, Plate K, Reif A, Reif PS, Reiss Y, Roeper J, Ronellenfitsch MW, Schorge S, Schratt G, Schwarzacher SW, Steinbach JP, Strzelczyk A, Triesch J, Wagner M, Walker MC, von Wegner F, Bauer S.

Epilepsy Behav. 2017 Nov;76:13-18. doi: 10.1016/j.yebeh.2017.06.041. Epub 2017 Sep 13. Review.

PMID:
28917501
25.

Personalized translational epilepsy research - Novel approaches and future perspectives: Part II: Experimental and translational approaches.

Bauer S, van Alphen N, Becker A, Chiocchetti A, Deichmann R, Deller T, Freiman T, Freitag CM, Gehrig J, Hermsen AM, Jedlicka P, Kell C, Klein KM, Knake S, Kullmann DM, Liebner S, Norwood BA, Omigie D, Plate K, Reif A, Reif PS, Reiss Y, Roeper J, Ronellenfitsch MW, Schorge S, Schratt G, Schwarzacher SW, Steinbach JP, Strzelczyk A, Triesch J, Wagner M, Walker MC, von Wegner F, Rosenow F.

Epilepsy Behav. 2017 Nov;76:7-12. doi: 10.1016/j.yebeh.2017.06.040. Epub 2017 Sep 14. Review.

PMID:
28917498
26.

Ictal conduction aphasia and ictal angular gyrus syndrome as rare manifestations of epilepsy: The importance of ictal testing during video-EEG monitoring.

Zöllner JP, Haag A, Hermsen A, Bauer S, Stahl F, Wulf K, Menzler K, Reif PS, Wagner M, Pagenstecher A, Sure U, Knake S, Rosenow F, Strzelczyk A.

Epilepsy Behav Case Rep. 2017 Aug 3;8:55-62. doi: 10.1016/j.ebcr.2017.07.003. eCollection 2017.

27.

Sure, or unsure? Measuring students' confidence and the potential impact on patient safety in multiple-choice questions.

Rangel RH, Möller L, Sitter H, Stibane T, Strzelczyk A.

Med Teach. 2017 Nov;39(11):1189-1194. doi: 10.1080/0142159X.2017.1362103. Epub 2017 Aug 11.

PMID:
28799435
28.

Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany.

Strzelczyk A, Ansorge S, Hapfelmeier J, Bonthapally V, Erder MH, Rosenow F.

Epilepsia. 2017 Sep;58(9):1533-1541. doi: 10.1111/epi.13837. Epub 2017 Jul 6.

29.

Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.

Steinig I, von Podewils F, Möddel G, Bauer S, Klein KM, Paule E, Reif PS, Willems LM, Zöllner JP, Kunz R, Runge U, Kurlemann G, Schubert-Bast S, Rosenow F, Strzelczyk A.

Epilepsia. 2017 Jul;58(7):1208-1216. doi: 10.1111/epi.13768. Epub 2017 May 8.

30.

Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals.

Strzelczyk A, Steinig I, Willems LM, Reif PS, Senft C, Voss M, Gaida B, von Podewils F, Rosenow F.

Epilepsy Behav. 2017 May;70(Pt A):177-181. doi: 10.1016/j.yebeh.2017.03.028. Epub 2017 Apr 17.

PMID:
28427029
31.

The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience.

Bauer S, Willems LM, Paule E, Petschow C, Zöllner JP, Rosenow F, Strzelczyk A.

Ther Adv Neurol Disord. 2017 Feb;10(2):103-126. doi: 10.1177/1756285616675777. Epub 2016 Nov 29. Review.

32.

Eslicarbazepine acetate as a therapeutic option in a patient with carbamazepine-induced rash and HLA-A*31:01.

Kay L, Willems LM, Zöllner JP, Reif PS, Klein KM, Rosenow F, Strzelczyk A.

Seizure. 2017 Apr;47:81-82. doi: 10.1016/j.seizure.2017.02.019. Epub 2017 Mar 18.

33.

Lacosamide in status epilepticus: Systematic review of current evidence.

Strzelczyk A, Zöllner JP, Willems LM, Jost J, Paule E, Schubert-Bast S, Rosenow F, Bauer S.

Epilepsia. 2017 Jun;58(6):933-950. doi: 10.1111/epi.13716. Epub 2017 Mar 11. Review.

34.

Epileptic Seizures in Patients Following Surgical Treatment of Acute Subdural Hematoma-Incidence, Risk Factors, Patient Outcome, and Development of New Scoring System for Prophylactic Antiepileptic Treatment (GATE-24 score).

Won SY, Dubinski D, Herrmann E, Cuca C, Strzelczyk A, Seifert V, Konczalla J, Freiman TM.

World Neurosurg. 2017 May;101:416-424. doi: 10.1016/j.wneu.2017.02.024. Epub 2017 Feb 16.

PMID:
28213197
35.

A systematic review of epileptic seizures in adults with subdural haematomas.

Won SY, Konczalla J, Dubinski D, Cattani A, Cuca C, Seifert V, Rosenow F, Strzelczyk A, Freiman TM.

Seizure. 2017 Feb;45:28-35. doi: 10.1016/j.seizure.2016.11.017. Epub 2016 Nov 25. Review.

36.

Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.

Kortland LM, Alfter A, Bähr O, Carl B, Dodel R, Freiman TM, Hubert K, Jahnke K, Knake S, von Podewils F, Reese JP, Runge U, Senft C, Steinmetz H, Rosenow F, Strzelczyk A.

Epilepsia. 2016 Dec;57(12):2056-2066. doi: 10.1111/epi.13584. Epub 2016 Oct 18.

37.

Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany.

Strzelczyk A, Bergmann A, Biermann V, Braune S, Dieterle L, Forth B, Kortland LM, Lang M, Peckmann T, Schöffski O, Sigel KO, Rosenow F.

Epilepsy Behav. 2016 Nov;64(Pt A):75-82. doi: 10.1016/j.yebeh.2016.07.037. Epub 2016 Oct 11.

PMID:
27732920
38.

Editorial for the in focus issue of Seizure-European Journal of Epilepsy on "Diagnostic and therapeutic use of invasive electrodes in epilepsy-A "highway" to personalized epilepsy treatment".

Rosenow F, Knake S, Strzelczyk A.

Seizure. 2016 Oct;41:189-90. doi: 10.1016/j.seizure.2016.07.017. Epub 2016 Aug 3. No abstract available.

39.

Estimating the Quantitative Demand of NOAC Antidote Doses on Stroke Units.

Pfeilschifter W, Farahmand D, Niemann D, Ikenberg B, Hohmann C, Abruscato M, Thonke S, Strzelczyk A, Hedtmann G, Neumann-Haefelin T, Kollmar R, Singer OC, Ferbert A, Steiner T, Steinmetz H, Reihs A, Misselwitz B, Foerch C.

Cerebrovasc Dis. 2016;42(5-6):415-420. Epub 2016 Jul 21.

PMID:
27438461
40.

Guideline conform initial monotherapy increases in patients with focal epilepsy: A population-based study on German health insurance data.

Ertl J, Hapfelmeier J, Peckmann T, Forth B, Strzelczyk A.

Seizure. 2016 Oct;41:9-15. doi: 10.1016/j.seizure.2016.07.001. Epub 2016 Jul 11.

41.

[Brivaracetam for add-on treatment in focal epilepsy].

Strzelczyk A, Steinig I, Klein KM, Willems LM, Knake S, Rosenow F, Bauer S.

Nervenarzt. 2016 Oct;87(10):1086-1093. Review. German.

PMID:
27389600
42.

Revised version of quality guidelines for presurgical epilepsy evaluation and surgical epilepsy therapy issued by the Austrian, German, and Swiss working group on presurgical epilepsy diagnosis and operative epilepsy treatment.

Rosenow F, Bast T, Czech T, Feucht M, Hans VH, Helmstaedter C, Huppertz HJ, Noachtar S, Oltmanns F, Polster T, Seeck M, Trinka E, Wagner K, Strzelczyk A.

Epilepsia. 2016 Aug;57(8):1215-20. doi: 10.1111/epi.13449. Epub 2016 Jun 29.

43.

The history of invasive EEG evaluation in epilepsy patients.

Reif PS, Strzelczyk A, Rosenow F.

Seizure. 2016 Oct;41:191-5. doi: 10.1016/j.seizure.2016.04.006. Epub 2016 Apr 19. Review.

44.

Predictors of New Cerebral Microbleeds in Patients with Antiplatelet Drug Therapy.

Wobith M, Mayer C, Belke M, Haag A, Gerstner A, Teepker M, Strzelczyk A, Werner R, Hamer HM, Rosenow F, Menzler K, Knake S.

J Stroke Cerebrovasc Dis. 2016 Jul;25(7):1671-1677. doi: 10.1016/j.jstrokecerebrovasdis.2016.01.052. Epub 2016 Apr 7.

PMID:
27067881
45.

[Impact of early benefit assessment on patients with epilepsy in Germany: Current healthcare provision and therapeutic needs].

Strzelczyk A, Hamer HM.

Nervenarzt. 2016 Apr;87(4):386-93. doi: 10.1007/s00115-016-0087-z. German.

PMID:
26927680
46.

Predictors of and attitudes toward counseling about SUDEP and other epilepsy risk factors among Austrian, German, and Swiss neurologists and neuropediatricians.

Strzelczyk A, Zschebek G, Bauer S, Baumgartner C, Grond M, Hermsen A, Kieslich M, Krämer G, Kurlemann G, May TW, Mayer T, Neubauer BA, Pfäfflin M, Plecko B, Ryvlin P, Schubert-Bast S, Stefan H, Trinka E, Knake S, Seifart C, Rosenow F.

Epilepsia. 2016 Apr;57(4):612-20. doi: 10.1111/epi.13337. Epub 2016 Feb 22.

47.

Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.

Strzelczyk A, Klein KM, Willems LM, Rosenow F, Bauer S.

Expert Rev Clin Pharmacol. 2016;9(5):637-45. doi: 10.1586/17512433.2016.1156529. Epub 2016 Mar 7. Review.

PMID:
26891946
48.

Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in Germany.

Nass RD, Kurth C, Kull A, Graf W, Kasper B, Hamer HM, Strzelczyk A, Elger CE, Steinhoff BJ, Surges R, Rosenow F.

Epilepsy Behav. 2016 Mar;56:54-8. doi: 10.1016/j.yebeh.2015.12.034. Epub 2016 Jan 30.

PMID:
26828693
49.

Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.

Strzelczyk A, Willems LM, Willig S, Rosenow F, Bauer S.

Expert Rev Clin Pharmacol. 2015;8(6):733-40. doi: 10.1586/17512433.2015.1091303. Epub 2015 Oct 5. Review.

PMID:
26436331
50.

Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany.

Riechmann J, Strzelczyk A, Reese JP, Boor R, Stephani U, Langner C, Neubauer BA, Oberman B, Philippi H, Rochel M, Seeger J, Seipelt P, Oertel WH, Dodel R, Rosenow F, Hamer HM; EpiPaed Study Group.

Epilepsia. 2015 Sep;56(9):1388-97. doi: 10.1111/epi.13089. Epub 2015 Aug 3.

Supplemental Content

Loading ...
Support Center